Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma

[1]  S. Baylin,et al.  Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines , 2018, Cell reports.

[2]  G. Mills,et al.  State-of-the-art strategies for targeting the DNA damage response in cancer , 2018, Nature Reviews Clinical Oncology.

[3]  S. Weiss,et al.  Isolation and Culture of Glioblastoma Brain Tumor Stem Cells. , 2018, Methods in molecular biology.

[4]  K. Kurian,et al.  Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells. , 2018, Cancer research.

[5]  H. Wakimoto,et al.  Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells , 2018, Journal of Virology.

[6]  Andrew R. Morton,et al.  Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. , 2018, Cell stem cell.

[7]  Samuel E. Jones,et al.  ATR Is a Therapeutic Target in Synovial Sarcoma. , 2017, Cancer research.

[8]  A. Chinnaiyan,et al.  Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate Cancer , 2017, Clinical Cancer Research.

[9]  A. Iafrate,et al.  Blockade of transforming growth factor‐β signaling enhances oncolytic herpes simplex virus efficacy in patient‐derived recurrent glioblastoma models , 2017, International journal of cancer.

[10]  Arnab Ray Chaudhuri,et al.  The multifaceted roles of PARP1 in DNA repair and chromatin remodelling , 2017, Nature Reviews Molecular Cell Biology.

[11]  Y. Drew,et al.  Targeting the ATR-CHK1 Axis in Cancer Therapy , 2017, Cancers.

[12]  I. Screpanti,et al.  PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma , 2017, Oncogene.

[13]  Alan Ashworth,et al.  PARP inhibitors: Synthetic lethality in the clinic , 2017, Science.

[14]  H. Wakimoto,et al.  Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma , 2017, Journal of the National Cancer Institute.

[15]  Gregory A. Breuer,et al.  2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity , 2017, Science Translational Medicine.

[16]  S. Ramaswamy,et al.  ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells , 2017, Genes & development.

[17]  W. Haas,et al.  Coupling of Homologous Recombination and the Checkpoint by ATR. , 2017, Molecular cell.

[18]  J. Doroshow,et al.  PARP Inhibitors in Reproductive System Cancers: Current Use and Developments , 2017, Drugs.

[19]  L. Zou,et al.  DNA Replication Checkpoint: New ATR Activator Identified , 2017, Current Biology.

[20]  Mark Morgan,et al.  Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models , 2016, Clinical Cancer Research.

[21]  A. Ashworth,et al.  PARP inhibitor combination therapy. , 2016, Critical reviews in oncology/hematology.

[22]  L. Zou,et al.  Functions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway. , 2016, Annual review of genetics.

[23]  S. Baylin,et al.  Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer. , 2016, Cancer cell.

[24]  Christopher J. Staples,et al.  Human CDK18 promotes replication stress signaling and genome stability , 2016, Nucleic acids research.

[25]  Maristela L Onozato,et al.  Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma , 2016, Clinical Cancer Research.

[26]  Alan Ashworth,et al.  BRCAness revisited , 2016, Nature Reviews Cancer.

[27]  Chien-Liang Liu,et al.  Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors , 2016, Nature Medicine.

[28]  Amanda J. Wilson,et al.  Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors , 2015, Nature Medicine.

[29]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[30]  Karen So,et al.  Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors , 2015, Advances in Therapy.

[31]  A. Kleijn,et al.  ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells , 2015, Journal of Translational Medicine.

[32]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[33]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[34]  A. Iafrate,et al.  Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH-Mutant Gliomas , 2014, Clinical Cancer Research.

[35]  Simon Kasif,et al.  Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.

[36]  L. Poellinger,et al.  Regulation of CDKN2B expression by interaction of Arnt with Miz-1 - a basis for functional integration between the HIF and Myc gene regulatory pathways , 2014, Molecular Cancer.

[37]  J. Seidman,et al.  5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. , 2014, The Journal of clinical investigation.

[38]  N. Manfrini,et al.  Regulation of the DNA damage response by cyclin-dependent kinases. , 2013, Journal of molecular biology.

[39]  William A. Flavahan,et al.  Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells , 2013, Cell Death and Differentiation.

[40]  C. Beier,et al.  Glioblastoma cancer stem cells--from concept to clinical application. , 2013, Cancer letters.

[41]  K. Flatten,et al.  ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. , 2013, Cancer research.

[42]  Simon Kasif,et al.  An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. , 2013, Cell reports.

[43]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[44]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[45]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[46]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[47]  Stephen Yip,et al.  Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. , 2012, Neuro-oncology.

[48]  P. Bosco,et al.  PARP-1 protein expression in glioblastoma multiforme , 2012, European journal of histochemistry : EJH.

[49]  O. Fernandez-Capetillo,et al.  Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. , 2012, The Journal of clinical investigation.

[50]  M. Barbacid,et al.  Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors , 2011, Nature Structural &Molecular Biology.

[51]  Ulrich Keller,et al.  Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells , 2011, Clinical Cancer Research.

[52]  Kwok-Kin Wong,et al.  COMPROMISED CDK1 ACTIVITY SENSITIZES BRCA-PROFICIENT CANCERS TO PARP INHIBITION , 2011, Nature Medicine.

[53]  Gary D Bader,et al.  Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.

[54]  A. Składanowski,et al.  H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy , 2010, Journal of nucleic acids.

[55]  A. Cole.  PCTK Proteins: The Forgotten Brain Kinases? , 2009, Neurosignals.

[56]  Khalid Shah,et al.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. , 2009, Cancer research.

[57]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[58]  Hui Wang,et al.  c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells , 2008, PloS one.

[59]  M. Wu,et al.  c‐Myc represses FOXO3a‐mediated transcription of the gene encoding the p27Kip1 cyclin dependent kinase inhibitor , 2008, Journal of cellular biochemistry.

[60]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[61]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[62]  K. Aldape,et al.  Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR , 2004, Genes, chromosomes & cancer.

[63]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[64]  J. Massagué,et al.  Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage , 2002, Nature.

[65]  Xian Chen,et al.  Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer. , 2018, Cancer research.

[66]  T. Cloughesy,et al.  Adult Glioblastoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  Alan Ashworth,et al.  Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. , 2014, Cancer research.

[68]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[69]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[70]  Jiri Bartek,et al.  ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks , 2006, Nature Cell Biology.